# Brain Imaging of Intranasal Oxytocin Treatment in Autism

> **NCT01945957** · PHASE1 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 33 (actual)

## Conditions studied

- Autism Spectrum Disorders

## Interventions

- **DRUG:** Oxytocin

## Key facts

- **NCT ID:** NCT01945957
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2017-04-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01945957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01945957, "Brain Imaging of Intranasal Oxytocin Treatment in Autism". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01945957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*